Parkinson's disease with dementia (PDD)
Takeda, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 10 Pt 2: 350-355
2011
ISSN/ISBN: 0047-1852 PMID: 22755212 Document Number: 650132
Document emailed within 1 workday
Related Documents
Shinotoh, H. 1999: Dementia with Lewy bodies and Parkinson's disease with dementia Rinsho Shinkeigaku 39(11): 1171-1172Perez Trullen, J.M.; Modrego, P.; Vasquez Andre, M.L. 1996: Subcortical dementia versus bradyphrenia in Parkinson disease Revue Neurologique (Paris) 152(4): 301-302
Mindham, R.H.; Biggins, C.A.; Boyd, J.L.; Harrop, F.M.; Madeley, P.; Randall, J.I.; Spokes, E.G. 1993: A controlled study of dementia in Parkinson's disease over 54 months Advances in Neurology 60: 470-474
Damulin, I.V. 2009: Pathogenetic and therapeutic aspects of dementia in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(2): 73-77
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1997: Neurofibrillary tangles and neuropil threads as a cause of dementia in Parkinson's disease Journal of Neural Transmission. Supplementum 51: 49-55
Levin, O.S.; Amosova, N.A.; Naĭmushina, T.V.; Smolentseva, I.G. 2004: Comparative study of Parkinson's disease and dementia with Lewy bodies Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(1): 3-10
Litvinenko, I.V.; Odinak, M.M.; Mogil'naia, V.I.; Perstenev, S.V. 2008: Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(10): 37-42
García-Mas, A.; Rossiñol, A.; Roca, M.; Lozano, R.; Rosselló, J.; Llinas, J. 1992: Effects of citicholine in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography Clinical Therapeutics 14(5): 718-729
Chan-Palay, V. 1993: Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy Advances in Neurology 60: 438-446
Mekawichai, P.; Choeikamhaeng, L. 2013: The prevalence and the associated factors of dementia in patients with Parkinson's disease at Maharat Nakhon Ratchasima Hospital Journal of the Medical Association of Thailand 96(4): 440-445
Krüger, R.; Weiss, D. 2011: Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease MMW Fortschritte der Medizin 153(14): 29-32; Quiz 33
Nishiyama, K.; Mizuno, T.; Sakuta, M.; Kurisaki, H. 1993: Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination Advances in Neurology 60: 479-483
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Shefer, V.F. 1984: Relation between the degree of severity of the dementia and the extent of the manifestation of the pathomorphological changes in the cerebral cortex in senile dementia and Alzheimer's disease Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(7): 1004-1006
Larsson, A. 2006: Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing Lakartidningen 103(19): 1537; Discussion: 1537-1538
Jindahra, P.; Vejjajiva, A.; Witoonpanich, R.; Sirisriro, R.; Sritara, C.; Pulkes, T. 2004: Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report) Journal of the Medical Association of Thailand 87(10): 1176-1181